ICR female scientist at work

Our discoveries defeat cancer 

 

At The Institute of Cancer Research, London, we’ve been pushing the boundaries of cancer research for more than 100 years. 

From identifying cancer-causing genes to discovering life-saving treatments, our research has transformed cancer care. And we are proud to have discovered more targeted therapies than any other academic centre globally.  

Our labs are home to 800 scientists, united by one mission: to make the discoveries that defeat cancer.

 

Research is where hope begins

Every day in the UK, more than 1,000 people hear the words: “You have cancer”. That’s one every 90 seconds.  

Our scientists are working hard to change this, unlocking innovative new ways to prevent, diagnose and treat cancer, and transforming outcomes for patients.  

 

'I still have a lot of living left to do'

In July 2007 I went on holiday for the first time with my husband Pete. We had a lovely time and photographs show me looking really well. So my diagnosis in September really was a bolt out of the blue.  

Remarkably, I was offered a place on a clinical trial for a new drug, the development of which was underpinned by research at The Institute of Cancer Research. Fifteen years on, I’m still taking olaparib. It’s given me a quality of life I could only have dreamed about. Read Sue's ovarian cancer story.

Alfred and Grace with quotation mark

'We need more treatments like abiraterone'

Abiraterone has saved my life and I am grateful for that. But not everyone is as fortunate as I was to get on that trial and respond to the drug as well as I did. We need more treatments like abiraterone. Drugs that enable people to live their lives with cancer, and live them well. It’s not just about surviving, it’s about so much more.

I am a man who, without clinical research would not be here today. I want to see more people benefit from the treatments of the future. Read Alfred's prostate cancer story.

Godfrey smiling with quotation mark

'New research into prostate cancer will take away people’s fear'

After my experience and as I get older, I want to know more.  We need to understand more about prostate cancer and why it is so aggressive in the black community. We need more research into this to be able to find solutions.  We need more research into prostate cancer full-stop.

Early diagnosis and early detection is so important. My story was very different to my dad’s because my disease was caught at an earlier stage. Read Godfrey's prostate cancer story.

 

This is just the start 

We have one mission – to make the discoveries that defeat cancer. Our scientists are at the forefront of cancer research, turning cutting-edge science into life-saving therapies. Find out more about our breakthroughs by signing up to our newsletter.

Sign up to Search newsletter

11/07/25

Scientists have uncovered a protein that acts like a ‘suit of armour’ for cancer cells, shielding them from hostile environments and allowing one of the deadliest forms of skin cancer to spread through the body. 

A team of researchers from The Institute of Cancer Research, London, has identified that a protein called SLC7A11 protects melanoma cells from damage as they pass through stressful environments in the body – allowing them to grow and spread unchecked.

The findings could open new avenues of research to disable the disease’s defences, offering fresh hope for thousands of patients.

The discovery, published in the journal Cell Reports, could also lead to new tests to spot these aggressive tumours.

Shielding cells from damage

Normally, cells are vulnerable to a process called oxidative stress – a kind of internal ‘rusting’ that damages and destroys them.

In research funded by Cancer Research UK, UK Research and Innovation (UKRI), Worldwide Cancer Research, Breast Cancer Now and Barts Charity, the team grew melanoma tumours in the lab. They saw that the more aggressive cells in the tumour – those around the border, with a rounder shape which enables them to invade other tissues – produced high amounts of the protein SLC7A11, which protects against oxidative stress.

They found that SLC7A11 acts not only as a protective shield against oxidative stress, but also as a suit of armour, controlling the cytoskeleton of the cancer cells – a structure that helps them become mobile and aggressive. When they knocked out the protein and stopped it from working, the cells were less round, and less able to grow and invade.

Blocking the ‘suit of armour’ protein

The team treated the melanoma tumours in the lab with drugs that inhibit SLC7A11 – after 72 hours, almost 75 per cent of the cells had died.

The ICR researchers hope that targeted SLC7A11 inhibitors can be developed in the future and trialled for the treatment of melanoma.

The role of antioxidants

Oxidative stress is a process that can be counteracted with antioxidants. The team found that when they treated the melanoma cells with the antioxidant glutathione, the cells became rounder – the more aggressive shape.

The antioxidant even protected the cells from damage caused by oxidative stress when the SLC7A11 protein was knocked out.

Antioxidant supplements have become popular and can be bought over the counter. The researchers therefore urge caution for patients with melanoma when taking any antioxidant supplements that could contain larger doses than recommended by health organisations.

The ICR – which is both a research institute and a charity – is helping more people survive melanoma skin cancer. Give a monthly donation to help us uncover how melanoma develops, grows and spreads – so we can develop new treatments to stop it in its tracks, and save more lives. 

Please donate today

‘A warning sign’

Professor Victoria Sanz-Moreno, Professor of Cancer Cell and Metastasis Biology at The Institute of Cancer Research, London, who led the study said:

“Our study has helped us to better understand how some cancer cells protect themselves from the stresses they encounter as they attempt to spread around the body. This could lead to new ways to identify and treat aggressive melanoma.

“High levels of the SLC7A11 protein seems to be a warning sign that a tumour is likely to spread. We have shown in the lab that targeting this protein leaves the cancer cells exposed and vulnerable to oxidative stress, blocking their ability to invade other tissues.

“If we take away the melanoma cells’ shield and armour, we could stop cancer in its tracks.

“Importantly, we’ve also shown that even if you remove the shield and armour, antioxidants can boost the aggressive nature of melanoma cells. We therefore urge caution when taking these over-the-counter supplements.”

‘New lines of attack against melanoma’

Professor Kristian Helin, Chief Executive of The Institute of Cancer Research, London, said:

“We know that cancer is most deadly once it has spread. Finding ways to stop cancer from spreading around the body is crucial to give patients more time living well. I hope this research opens the door to new lines of attack against melanoma in the future.”

‘Complex relationship between antioxidant supplements and cancer’

Dr Dani Edmunds, Research Information Manager at Cancer Research UK, said:

“Once cancer starts spreading, treatment options become more limited. The earlier we can stop it from spreading, the better the chances of long-term survival.  

“It’s promising to see that melanoma skin cancer could be stopped from spreading by stripping away its defences. While this is early-stage research, future clinical trials could help us understand how this approach works in the body and how best we can use it to save and improve lives.

“This research also highlights the complex relationship between antioxidant supplements and cancer. We know that eating a healthy balanced diet can help to reduce the risk of cancer. If you have been diagnosed with cancer, we strongly advise talking to your doctor before taking any over-the-counter health supplements.”

Make a donation today

A monthly gift can help us unlock innovative new ways to prevent, diagnose and treat cancer, and transforming outcomes for patients.
With Gift Aid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.

Donating can help us unlock innovative new ways to prevent, diagnose and treat cancer, and transforming outcomes for patients.
With Gift Aid you'll also be able to add 25% at no extra cost to you

Please choose a donation amount.